Cargando…
A 12 Week, Open Label, Phase I/IIa Study Using Apatone(®) for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy
Purpose: To evaluate the safety and efficacy of oral Apatone(®) (Vitamin C and Vitamin K(3)) administration in the treatment of prostate cancer in patients who failed standard therapy. Materials and Methods: Seventeen patients with 2 successive rises in PSA after failure of standard local therapy we...
Autores principales: | Tareen, Basir, Summers, Jack L., Jamison, James M., Neal, Deborah R., McGuire, Karen, Gerson, Lowell, Diokno, Ananias |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2288789/ https://www.ncbi.nlm.nih.gov/pubmed/18392145 |
Ejemplares similares
-
2-Bromo-1,4-naphthoquinone: a potentially improved substitute of menadione in Apatone™ therapy
por: Graciani, F.S., et al.
Publicado: (2012) -
The impact of COVID-19 on urologic practice, medical education, and training
por: Diokno, Ananias C., et al.
Publicado: (2020) -
Novel Application of Statistical Methods to Identify New Urinary Incontinence Risk Factors
por: Ogunyemi, Theophilus O., et al.
Publicado: (2012) -
Underactive Bladder; Review of Progress and Impact From the International CURE-UAB Initiative
por: Chancellor, Michael B., et al.
Publicado: (2020) -
News credibility labels have limited average effects on news diet quality and fail to reduce misperceptions
por: Aslett, Kevin, et al.
Publicado: (2022)